rewirebio.iobenchmarks
Protocol

CASP16 affinity challenge, Boltz-2 against the top-ranked participants

Scores predicted affinities against the withheld CASP16 measurements for the chymase and autotaxin series, computing each metric inside one series and averaging across series weighted by compound count.

10 evaluations · 90 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

10 recorded evaluations, 90 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

10 evaluations · 90 results. Different protocols are not a single leaderboard.

Protocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants · Dataset: CASP16 affinity targets L1000 and L3000

Sorted by Kendall tau (target average as printed, computed per assay and weighted by compound count) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationKendall tau (target average as printed, computed per assay and weighted by compound count)MAE (centered, computed per assay and averaged across assays weighted by compound count)MAE (non-centered, computed per assay and averaged across assays weighted by compound count)MAE (pairwise, target average as printed, computed per assay and weighted by compound count)Pearson (target average as printed, computed per assay and weighted by compound count)Proportion (within 1 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)Proportion (within 1 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)Proportion (within 2 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)Proportion (within 2 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)
Boltz-2 affinity predictionEvaluation0.45 (best in column)0.95 (best in column)1.281.36 (best in column)0.65 (best in column)0.61 (best in column)0.480.90.81
CASP16 group LG016 affinity submissionEvaluation0.421.031.09 (best in column)1.430.540.510.53 (best in column)0.91 (best in column)0.83 (best in column)
CASP16 group LG082 affinity submissionEvaluation0.361.121.171.550.380.470.490.850.83 (best in column)
BACPI ligand-only ablation (GAT)Evaluation0.351.131.281.580.50.490.440.840.79
CASP16 group LG204 affinity submissionEvaluation0.34--------
CASP16 group LG055 affinity submissionEvaluation0.331.121.291.590.470.530.450.840.78
CASP16 group LG207 affinity submissionEvaluation0.321.191.321.650.380.470.480.830.74
BACPI as trained for the Boltz-2 affinity baselinesEvaluation0.311.11.251.550.410.510.450.890.81
CASP16 group LG008 affinity submissionEvaluation0.291.161.431.620.380.510.390.850.72
Boltz-2 ipTM as an affinity scoreEvaluation0.07N/AN/AN/A0.12N/AN/AN/AN/A
All 90 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.31 Kendall tau (target average as printed, computed per assay and weighted by compound count)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Kendall tau", sub-column "target avg." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
1.1 MAE (centered, computed per assay and averaged across assays weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "MAE", sub-column "cent." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
1.25 MAE (non-centered, computed per assay and averaged across assays weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "MAE", sub-column "non-cent." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.41 Pearson (target average as printed, computed per assay and weighted by compound count)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Pearson R", sub-column "target avg." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
1.55 MAE (pairwise, target average as printed, computed per assay and weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Pairwise MAE", sub-column "target avg." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.51 Proportion (within 1 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Perc. within 1", sub-column "cent." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.45 Proportion (within 1 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Perc. within 1", sub-column "non-cent." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.89 Proportion (within 2 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Perc. within 2", sub-column "cent." (text-layer line 1756)
Configuration: BACPI as trained for the Boltz-2 affinity baselinesProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.81 Proportion (within 2 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BACPI on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "BACPI", column "Perc. within 2", sub-column "non-cent." (text-layer line 1756)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.07 Kendall tau (target average as printed, computed per assay and weighted by compound count)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Kendall tau", sub-column "target avg." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A MAE (centered, computed per assay and averaged across assays weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "MAE", sub-column "cent." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A MAE (non-centered, computed per assay and averaged across assays weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "MAE", sub-column "non-cent." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.12 Pearson (target average as printed, computed per assay and weighted by compound count)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Pearson R", sub-column "target avg." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A MAE (pairwise, target average as printed, computed per assay and weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Pairwise MAE", sub-column "target avg." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A Proportion (within 1 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Perc. within 1", sub-column "cent." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A Proportion (within 1 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Perc. within 1", sub-column "non-cent." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A Proportion (within 2 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Perc. within 2", sub-column "cent." (text-layer line 1754)
Configuration: Boltz-2 ipTM as an affinity scoreProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
N/A Proportion (within 2 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 iptm on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2 iptm", column "Perc. within 2", sub-column "non-cent." (text-layer line 1754)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.45 Kendall tau (target average as printed, computed per assay and weighted by compound count)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "Kendall tau", sub-column "target avg." (text-layer line 1747)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.95 MAE (centered, computed per assay and averaged across assays weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "MAE", sub-column "cent." (text-layer line 1747)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
1.28 MAE (non-centered, computed per assay and averaged across assays weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "MAE", sub-column "non-cent." (text-layer line 1747)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.65 Pearson (target average as printed, computed per assay and weighted by compound count)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "Pearson R", sub-column "target avg." (text-layer line 1747)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
1.36 MAE (pairwise, target average as printed, computed per assay and weighted by compound count)
kilocalorie-per-mole · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "Pairwise MAE", sub-column "target avg." (text-layer line 1747)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.61 Proportion (within 1 kcal/mol, centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "Perc. within 1", sub-column "cent." (text-layer line 1747)
Configuration: Boltz-2 affinity predictionProtocol: CASP16 affinity challenge, Boltz-2 against the top-ranked participants
Dataset: CASP16 affinity targets L1000 and L3000
0.48 Proportion (within 1 kcal/mol, non-centered, computed per assay and averaged across assays weighted by compound count)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Boltz-2 on the CASP16 affinity challenge

uc-leadopt-20261022-protocol-boltz2-casp16

Aggregation: Not reported

Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction, supplementary appendix · Table 14, row "Boltz-2", column "Perc. within 1", sub-column "non-cent." (text-layer line 1747)

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
4
paper compilation
6

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Protocol-specific valid geometric or structural control

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Upstream conventional structural reference with matched templates and cutoffs

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-10-22-1b7cf027e4f6. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-leadopt-20261022-protocol-boltz2-casp16

areas
molecular-interactions
contexts
research
protocol
Pearson R, Kendall tau, pairwise MAE, MAE (non-centered and centered) and the fraction of predictions within 1 and 2 kcal/mol, as printed in Table 14
version
Boltz-2 supplement (bioRxiv v1) Table 14
aggregation
Calculated per assay and averaged across assays with weight proportional to the number of compounds in each assay (appendix D.2.2, 'Evaluation metrics'). The Pearson R, Kendall tau and PMAE columns are printed under the label 'target avg.'; assays and targets are not the same unit, and the source does not reconcile the printed label with the stated computation.
metric definition
Appendix D.2.2 'Evaluation metrics': Pearson R, Kendall tau, pairwise MAE (PMAE), MAE and the fraction of predictions within 1 and 2 kcal/mol, each computed per assay and averaged across assays weighted by compound count, with predictions converted to kcal/mol first; the centered variants translate each assay's predictions to the ground-truth mean
control
The sequence-level filtering described in appendix D.2.1 was not applied to CASP16, because the CASP16 data was released after the training-data cutoff. The maximum Tanimoto similarity of test compounds to the affinity training set is stated as 0.41 for L1000 and 0.59 for L3000.
heldout test
Blind challenge data released after the training-data cutoff; no sequence filtering was applied
source locator
Table 14, 'CASP16 competition'
limitations
One value per cell with no uncertainty.; The column headers read 'target avg.' while appendix D.2.2 defines the aggregation as a compound-weighted mean across assays; the source does not reconcile the two labels.; No per-series value is printed, so the table cannot say how either target was ranked on its own.; The participant rows are anonymous CASP16 group identifiers and the supplement says nothing about what methods they used.; The supplement does not state how the participants' submissions were obtained or re-scored.; The mmseqs 90% identity filtering applied to the other affinity benchmarks was not applied here.; The units of the pairwise MAE and MAE columns are not printed in the table header; appendix D.2.2 states that all predictions are converted to kcal/mol before the metrics are computed.; The 'Perc. within 1' and 'Perc. within 2' headers say percentage, but the printed values lie on a 0 to 1 scale.; One target can carry several assays, so a compound-weighted mean across assays is not a mean over targets even where the two happen to coincide; Ross et al. 2023 Table 1 surveys this collection's own proteins measured in more than one assay.
missing metadata
uncertainty reporting: reason: unreported; note: Table 14 prints no uncertainty
review
method: source-hash-verification; pdf-text-parse; independent-cell-check; rendered-source-visual-check; ai-assisted-source-review; method note: Re-retrieved all three sources and matched each pinned SHA-256. Re-rendered the Boltz-2 supplement with pdftotext -layout (poppler 26.08.0) and matched the text layer's recorded SHA-256. Re-read all 256 cells with a parser written for this review that does not import the extraction script, matching each result to its cell through its own source_locator, and separately read appendix tables 11, 12 and 14 from PNG renderings of PDF pages 29 and 30 at 160 dpi, and Ross Table 3 from the pinned XML markup. Checked printed value, numeric value, locator, metric concept, qualifier, direction, unit, uncertainty and the linked configuration, protocol and dataset, and that every N/A or '-' cell is recorded as missing with a reason.; reviewer: claude; reviewer note: Claude review agent, independent of the extraction agent; no human review claimed; reviewed at: 2026-10-22T13:40:00Z; artifact sha256: be867a5d92add8b223d47d882a4213ad489741f3e4d5081a0901a54370342569; retrieval url: https://www.ebi.ac.uk/europepmc/webservices/rest/PMC12262699/supplementaryFiles
Related records

Suggest a correction